Logo image of BNGO

BIONANO GENOMICS INC (BNGO) Stock Price, Quote, News and Overview

NASDAQ:BNGO - Nasdaq - US09075F3055 - Common Stock - Currency: USD

5.14  +0.07 (+1.38%)

After market: 5.16 +0.02 (+0.39%)

BNGO Quote, Performance and Key Statistics

BIONANO GENOMICS INC

NASDAQ:BNGO (1/29/2025, 8:07:09 PM)

After market: 5.16 +0.02 (+0.39%)

5.14

+0.07 (+1.38%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High81
52 Week Low4.95
Market Cap524.23M
Shares101.99M
Float101.81M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO08-01 2018-08-01


BNGO short term performance overview.The bars show the price performance of BNGO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

BNGO long term performance overview.The bars show the price performance of BNGO in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of BNGO is 5.14 USD. In the past month the price decreased by -59.21%. In the past year, price decreased by -92.35%.

BIONANO GENOMICS INC / BNGO Daily stock chart

BNGO Latest News, Press Releases and Analysis

News Image
3 days ago - Chartmill

Which stocks are experiencing notable movement on Monday?

Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.

News Image
3 days ago - Chartmill

These stocks are moving in today's session

Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.

News Image
3 days ago - Chartmill

Traders are paying attention to the gapping stocks in Monday's session.

Let's have a look at the gap up and gap down stocks in today's session.

News Image
7 days ago - Bionano Genomics

Bionano Announces Effective Date of Reverse Stock Split

Bionano Announces Effective Date of Reverse Stock Split...

News Image
23 days ago - Bionano Genomics

Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules...

BNGO Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 26.52 217.35B
DHR DANAHER CORP 29.87 161.60B
A AGILENT TECHNOLOGIES INC 27.81 41.95B
IQV IQVIA HOLDINGS INC 18.24 35.95B
MTD METTLER-TOLEDO INTERNATIONAL 35.01 28.18B
WST WEST PHARMACEUTICAL SERVICES 50.23 24.59B
WAT WATERS CORP 35.48 24.00B
ILMN ILLUMINA INC 76.14 20.89B
ICLR ICON PLC 14.12 16.36B
RVTY REVVITY INC 26.11 15.03B
AVTR AVANTOR INC 21.93 14.63B
TECH BIO-TECHNE CORP 40.13 11.41B

About BNGO

Company Profile

BNGO logo image Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The company is headquartered in San Diego, California and currently employs 344 full-time employees. The company went IPO on 2018-08-01. The firm offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. The company also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The firm additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The firm markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Company Info

BIONANO GENOMICS INC

9640 Towne Centre Drive, 9640 Towne Centre Drive

San Diego CALIFORNIA 92121 US

CEO: R. Erik Holmlin

Employees: 344

Company Website: https://bionano.com/

Investor Relations: https://ir.bionanogenomics.com/

Phone: 18588887600

BNGO FAQ

What is the stock price of BNGO?

The current stock price of BNGO is 5.14 USD.


What is the symbol for BIONANO GENOMICS INC stock?

The exchange symbol of BIONANO GENOMICS INC is BNGO and it is listed on the Nasdaq exchange.


On which exchange is BNGO stock listed?

BNGO stock is listed on the Nasdaq exchange.


Is BNGO a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for BNGO, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of BNGO.


Does BNGO stock pay dividends?

BNGO does not pay a dividend.


What is the Price/Earnings (PE) ratio of BNGO?

BNGO does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.54).


What is the Short Interest ratio of BNGO stock?

The outstanding short interest for BNGO is 17.34% of its float.


BNGO Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

BNGO Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to BNGO. BNGO has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BNGO Financial Highlights

Over the last trailing twelve months BNGO reported a non-GAAP Earnings per Share(EPS) of -1.54. The EPS decreased by 67.51% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -155.43%
ROE -277.86%
Debt/Equity 0.07
Chartmill High Growth Momentum
EPS Q2Q%60%
Sales Q2Q%-34.83%
EPS 1Y (TTM)67.51%
Revenue 1Y (TTM)-0.85%

BNGO Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 49% to BNGO. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 64.63% and a revenue growth -19.65% for BNGO


Ownership
Inst Owners11.76%
Ins Owners0.09%
Short Float %17.34%
Short Ratio2.21
Analysts
Analysts48.89
Price Target1.02 (-80.16%)
EPS Next Y64.63%
Revenue Next Year-19.65%